Istituto Nazionale Tumori Regina Elena Irccs
Rome 00144
0 studies enrolling now · 2 studies all time
What they study most
Advanced Malignancies, Endometrial Cancer
Studies at this site
- Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) — Running, not enrolling
- The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies. — Stopped early